Maven Securities LTD bought a new position in shares of Organon & Co. (NYSE:OGN – Free Report) in the second quarter, HoldingsChannel.com reports. The institutional investor bought 434,200 shares of the company’s stock, valued at approximately $5,879,000. Other hedge funds have also recently bought and sold shares of the company. Royal Bank of Canada increased […]

Maven Securities LTD purchased a new position in shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 40,000 shares of the company’s stock, valued at approximately $3,551,000. A number of other hedge funds and other institutional investors […]